---
title: Publications
---

<h3>2021</h3>
<table><tbody>
<tr><td width="100%">SC Ifeagwu, <b>JC Yang</b>, R Parkes-Ratanshi, C Brayne (2021) <a href="https://scholar.google.com/scholar?oi=bibs&cluster=2165629957189959128&btnI=1&hl=en">Health financing for universal health coverage in Sub-Saharan Africa: a systematic review</a>, Global health research and policy, 6 (1), 1-9</td></tr>
<tr><td width="100%">B Rosner, J Neicun, <b>JC Yang</b>, A Roman-Urrestarazu (2021) <a href="https://scholar.google.com/scholar?oi=bibs&cluster=12712246236101272838&btnI=1&hl=en">Substance use among sexual minorities in the US?Linked to inequalities and unmet need for mental health treatment? Results from the National Survey on Drug Use and Health (NSDUH)</a>, Journal of Psychiatric Research, 135, 107-118</td></tr>
</tbody></table>
<h3>2020</h3>
<table><tbody>
<tr><td width="100%"><b>JC Yang</b>, A Roman-Urrestarazu, C Brayne (2020) <a href="https://scholar.google.com/scholar?oi=bibs&cluster=11375825799266435379&btnI=1&hl=en">Responses among substance abuse treatment providers to the opioid epidemic in the USA: Variations in buprenorphine and methadone treatment by geography, operational, and??</a>, Plos one, 15 (3), e0229787</td></tr>
<tr><td width="100%">J Neicun, <b>JC Yang</b>, H Shih, P Nadella, R van Kessel, A Negri et al. (2020) <a href="https://scholar.google.com/scholar?oi=bibs&cluster=15158276950846183007&btnI=1&hl=en">Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population??</a>, Plos one, 15 (10), e0241056</td></tr>
</tbody></table>
<h3>2019</h3>
<table><tbody>
<tr><td width="100%">B Rosner, J Neicun, <b>JC Yang</b>, A Roman-Urrestarazu (2019) <a href="https://scholar.google.com/scholar?oi=bibs&cluster=6757181088273792934&btnI=1&hl=en">Opioid prescription patterns in Germany and the global opioid epidemic: systematic review of available evidence</a>, PLoS One, 14 (8), e0221153</td></tr>
<tr><td width="100%">A Roman-Urrestarazu, <b>J Yang</b>, R Robertson, A McCallum, C Gray et al. (2019) <a href="https://scholar.google.com/scholar?oi=bibs&cluster=4022466425480781686&btnI=1&hl=en">Brexit threatens the UK?s ability to tackle illicit drugs and organised crime: What needs to happen now?</a>, Health policy, 123 (6), 521-525</td></tr>
<tr><td width="100%"><b>JC Yang</b>, A Roman-Urrestarazu, C Brayne (2019) <a href="https://scholar.google.com/scholar?oi=bibs&cluster=7822239896019220876&btnI=1&hl=en">Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17</a>, Plos one, 14 (12), e0226349</td></tr>
<tr><td width="100%"><b>JC Yang</b>, A Roman-Urrestarazu, M McKee, C Brayne (2019) <a href="https://scholar.google.com/scholar?oi=bibs&cluster=7190112056285009233&btnI=1&hl=en">Demographic, socioeconomic, and health correlates of unmet need for mental health treatment in the United States, 2002?16: evidence from the national surveys on drug use and health</a>, International journal for equity in health, 18 (1), 1-11</td></tr>
<tr><td width="100%">J Neicun, M Steenhuizen, R van Kessel, <b>JC Yang</b>, A Negri et al. (2019) <a href="https://scholar.google.com/scholar?oi=bibs&cluster=5179860702901619149&btnI=1&hl=en">Mapping novel psychoactive substances policy in the EU: The case of Portugal, the Netherlands, Czech Republic, Poland, the United Kingdom and Sweden</a>, Plos one, 14 (6), e0218011</td></tr>
</tbody></table>
<h3>2018</h3>
<table><tbody>
<tr><td width="100%"><b>JC Yang</b>, A Roman-Urrestarazu, C Brayne (2018) <a href="https://scholar.google.com/scholar?oi=bibs&cluster=15164222940132416176&btnI=1&hl=en">Binge alcohol and substance use across birth cohorts and the global financial crisis in the United States</a>, PLoS One, 13 (6), e0199741</td></tr>
<tr><td width="100%">A Roman-Urrestarazu, <b>JC Yang</b>, S Ettelt, I Thalmann, VS Ravest et al. (2018) <a href="https://scholar.google.com/scholar?oi=bibs&cluster=8191291307959589529&btnI=1&hl=en">Private health insurance in Germany and Chile: two stories of co-existence, segmentation and conflict</a>, International journal for equity in health, 17 (1), 1-14</td></tr>
<tr><td width="100%">A Roman-Urrestarazu, R Robertson, <b>J Yang</b>, A McCallum, C Gray et al. (2018) <a href="https://scholar.google.com/scholar?oi=bibs&cluster=16440607293330664222&btnI=1&hl=en">European Monitoring Centre for Drugs and Drug Addiction has a vital role in the UK?s ability to respond to illicit drugs and organised crime</a>, bmj, 362</td></tr>
<tr><td width="100%">A Roman-Urrestarazu, R Robertson, <b>J Yang</b> (2018) <a href="https://scholar.google.com/scholar?oi=bibs&cluster=11557515016762068710&btnI=1&hl=en">European Monitoring Centre for Drugs and Drug Addiction: European Monitoring Centre for Drugs and Drug Addiction has a vital role in the UK?s ability to respond to illicit??</a>, Bmj, 362</td></tr>
<tr><td width="100%">M Prilutskaya, <b>JC Yang</b>, A Roman-Urrestarazu (2018) <a href="https://scholar.google.com/scholar?oi=bibs&cluster=NA&btnI=1&hl=en">Synthetic Cannabinoids, Opioids, and Polydrug Use: Clinical Implications</a>, Handbook of Novel Psychoactive Substances, 169-184</td></tr>
</tbody></table>
